US 9278125
Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants
granted A61KA61K2039/522A61K2039/54
Quick answer
US patent 9278125 (Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants) held by Sanaria Inc. expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sanaria Inc.
- Grant date
- Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/522, A61K2039/54, A61K2039/55511, A61K39/015